Immunogenicity Assessment of Lipegfilgrastim in Patients with Breast Cancer Receiving Chemotherapy

Lipegfilgrastim is a long-acting, once-per-cycle, glycopegylated recombinant granulocyte colony-stimulating factor (G-CSF) used to prevent neutropenia in patients receiving myelosuppressive chemotherapy. This integrated analysis examined the immunogenicity of lipegfilgrastim and its potential clinic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunol Res
Autori principali: Zou, Linglong, Buchner, Anton, Roberge, Martin, Liu, Patrick M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4935921/
https://ncbi.nlm.nih.gov/pubmed/27419145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/9248061
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi